Doctors find their voices to combat “infodemic” of fake news


Leave a Comment

Enter the debate: reply to an existing comment
3 comments

  1. Civi Jacobsen

    Thank you for your article. In large part i agree. What I would add is that there are very few thoughtful conversations- especially in a crisis. Whether vaccinations, fluoride treatments or cancer therapy there is no one solution that works for everyone, everywhere, everytime. Btw I am not supporting any statements made by Mr. Trump. And….I wouldn’t leave itvus to social media giants to do the right thing on their own. Thank you for putting the conversation in view. Thank you for all your hard qork.

  2. Gunther Eysenbach

    It’s an interesting debate, but let’s not forget that it is as old as the Internet itself and there is a considerable body of evidence and methodological approaches since the first infodemiology studies were published about 20 years ago… See https://www.jmir.org/collection/view/69 for examples. Of course, the physicists writing this “seminal” paper in Nature wouldn’t know anything about that and fail to tie their research to the exisiting body of knowledge

  3. ediriweera desapriya

    Medicine and public health is desperately exploring applicability of outcomes of the expedited research with complex data sets and sophisticated data analysis to address dire needs of saving lives from this unknown highly contagious deadly COVID 19. It is our utmost duty to save lives but scientific integrity needs to be the guiding principal of all our noble scientific research. Mere financial interest and the scientific integrity cannot simply achieve at the same time. Two recent studies have been retracted because data integrity and serious issues pertaining to the ethics of the way these studies are conducted (1, 2). Both studies used data from an international database held by Surgisphere Corporation which included electronic health records from 169 hospitals on three continents:
    “WHY are very powerful corporate-government stakeholders so intent on killing a drug with a 70 year track record? Because the drug works against the pandemic; it is readily available, and costs very little. Therefore, it poses a financial threat to both pharma companies and their partners in government and academia, those who are intent on profiting from the COVID-19 pandemic” (3).
    REFERENCES:
    (1). Hydroxychloroquine or Chloroquine With or Without a Macrolide for Treatment of COVID-19: A Multinational Registry Analysis- https://pubmed.ncbi.nlm.nih.gov/32450107/
    (2). Cardiovascular Disease, Drug Therapy, and Mortality in COVID-19. The study examined the effect of preexisting treatment with angiotensin-converting enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) on COVID-19- https://pubmed.ncbi.nlm.nih.gov/32356626/?from_single_result=Cardiovascular+Disease%2C+Drug+Therapy%2C+and+Mortality+in+COVID-19.+The+study+examined+the+effect+of+preexisting+treatment+with+angiotensin-converting+enzyme+%28ACE%29+inhibitors+and+angiotensin-receptor+blockers+%28ARBs%29+on+COVID-19
    (3). Editors of The Lancet and the New England Journal of Medicine: Pharmaceutical Companies are so Financially Powerful They Pressure us to Accept Papers-https://healthimpactnews.com/2020/editors-of-the-lancet-and-the-new-england-journal-of-medicine-pharmaceutical-companies-are-so-financially-powerful-they-pressure-us-to-accept-papers/

Submit a comment